197 related articles for article (PubMed ID: 24568494)
1. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.
Cai XY; Wang JX; Yi Y; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Asian Pac J Cancer Prev; 2014; 15(2):775-80. PubMed ID: 24568494
[TBL] [Abstract][Full Text] [Related]
2. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection.
Zhu W; Guo L; Zhang B; Lou L; Lin Z; Zhu X; Ren N; Dong Q; Ye Q; Qin L
Ann Surg Oncol; 2014 Apr; 21(4):1304-13. PubMed ID: 24366422
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection.
Wang JX; Yi Y; Li YW; Cai XY; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
BMC Cancer; 2014 Apr; 14():297. PubMed ID: 24774224
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.
Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J
Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513
[TBL] [Abstract][Full Text] [Related]
8. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
10. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
Fu YP; Yi Y; Cai XY; Sun J; Ni XC; He HW; Wang JX; Lu ZF; Huang JL; Cao Y; Zhou J; Fan J; Qiu SJ
Br J Cancer; 2016 Mar; 114(7):767-76. PubMed ID: 27002937
[TBL] [Abstract][Full Text] [Related]
13. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
14. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Zhu XD; Zhang JB; Zhuang PY; Zhu HG; Zhang W; Xiong YQ; Wu WZ; Wang L; Tang ZY; Sun HC
J Clin Oncol; 2008 Jun; 26(16):2707-16. PubMed ID: 18509183
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.
Lu SD; Wang YY; Peng NF; Peng YC; Zhong JH; Qin HG; Xiang BD; You XM; Ma L; Li LQ
Medicine (Baltimore); 2016 Feb; 95(5):e2722. PubMed ID: 26844516
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.
Liu H; Liu W; Liu Z; Liu Y; Zhang W; Xu L; Xu J
Tumour Biol; 2015 Jul; 36(7):5039-49. PubMed ID: 25722111
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
